Literature DB >> 32126879

Elevation of microRNA-512-5p inhibits MUC1 to reduce radioresistance in cervical cancer.

Jingru Zhang1, Ling Wang1, Jing Jiang1, Zhiwei Qiao1.   

Abstract

Researches about the role of several microRNAs (miRNAs) in cervical cancer were performed by previous studies, but the function of miR-512-5p in cervical cancer is rare to see. Thus, we aimed to investigate the effect and mechanism of miR-512-5p on radiosensitivity in cervical cancer by regulating MUC1 expression. First, 111 patients with cervical cancer were divided into radiotherapy sensitive group and radiotherapy resistant group. After that, miR-512-5p expression in cancer tissues from two groups was detected. Next, RT-qPCR was used to detect miR-512-5p expression in radiotherapy resistant cervical cancer cells SiHa and radiotherapy sensitive cervical cancer cells Me180. Moreover, SiHa and Me180 cells were treated with miR-512-5p overexpression and MUC1 poor expression plasmids. With 0 Gy, 2 Gy, 4 Gy, 6 Gy and 8 Gy irradiation, proliferation, colony formation ability and apoptosis of cervical cancer cells were determined. Also, cell lines that overexpressed miR-512-5p and overexpressed MUC1 were then constructed to observe the changes in cell radiosensitivity. MiR-512-5p was down-regulated and MUC1 was up-regulated in radiotherapy resistant cervical cancer tissues and cells. Overexpression of miR-512-5p and down-regulation of MUC1 increased the apoptosis and reduced cell survival rate of cervical cancer cells after radiotherapy. Overexpression of miR-512-5p reversed the effect of MUC1 overexpression on decreasing cell apoptosis and elevating cell survival rate of cervical cancer cells. Our study provides evidence that elevation of miR-512-5p contributes to the reduction of radioresistance in cervical cancer cells by inhibiting MUC1 expression.

Entities:  

Keywords:  Cervical cancer; microRNA-512-5p; radioresistance

Mesh:

Substances:

Year:  2020        PMID: 32126879      PMCID: PMC7145329          DOI: 10.1080/15384101.2019.1711314

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  30 in total

1.  MUC1-C drives MYC in multiple myeloma.

Authors:  Ashujit Tagde; Hasan Rajabi; Audrey Bouillez; Maroof Alam; Reddy Gali; Shannon Bailey; Yu-Tzu Tai; Teru Hideshima; Kenneth Anderson; David Avigan; Donald Kufe
Journal:  Blood       Date:  2016-02-23       Impact factor: 22.113

2.  Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells.

Authors:  Solange Tréhoux; Fatima Lahdaoui; Yannick Delpu; Florence Renaud; Emmanuelle Leteurtre; Jérôme Torrisani; Nicolas Jonckheere; Isabelle Van Seuningen
Journal:  Biochim Biophys Acta       Date:  2015-05-31

3.  Overexpression of astrocyte elevated gene-1 (AEG-1) in cervical cancer and its correlation with angiogenesis.

Authors:  Jian-Qin Yu; Qing Zhou; Hua Zhu; Fei-Yun Zheng; Zhi-Wen Chen
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.

Authors:  Shihong Cao; Weiliang Liu; Feng Li; Weipin Zhao; Chuan Qin
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  MicroRNA-125 modulates radioresistance through targeting p21 in cervical cancer.

Authors:  Abraham Pedroza-Torres; Alma D Campos-Parra; Oliver Millan-Catalan; Yahir A Loissell-Baltazar; Horacio Zamudio-Meza; David Cantú de León; Gonzalo Montalvo-Esquivel; David Isla-Ortiz; Luis A Herrera; Óscar Ángeles-Zaragoza; Guadalupe Robelo-Romero; Ángel Herrera-Gómez; Carlos Pérez-Plasencia
Journal:  Oncol Rep       Date:  2018-01-18       Impact factor: 3.906

6.  MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition.

Authors:  H Rajabi; M Alam; H Takahashi; A Kharbanda; M Guha; R Ahmad; D Kufe
Journal:  Oncogene       Date:  2013-04-15       Impact factor: 9.867

7.  Increased expression of MUC1 in advanced pancreatic cancer.

Authors:  Yuji Hinoda; Yoshito Ikematsu; Michiko Horinochi; Shuji Sato; Kotaro Yamamoto; Tomoko Nakano; Mikiko Fukui; Yutaka Suehiro; Yuichiro Hamanaka; Yoshiro Nishikawa; Hideo Kida; Shinji Waki; Masaaki Oka; Kohzoh Imai; Suguru Yonezawa
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

8.  Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.

Authors:  Lynette Denny; Isaac Adewole; Rose Anorlu; Greta Dreyer; Manivasan Moodley; Trudy Smith; Leon Snyman; Edwin Wiredu; Anco Molijn; Wim Quint; Gunasekaran Ramakrishnan; Johannes Schmidt
Journal:  Int J Cancer       Date:  2013-11-14       Impact factor: 7.396

9.  Integrated genomic and molecular characterization of cervical cancer.

Authors: 
Journal:  Nature       Date:  2017-01-23       Impact factor: 49.962

10.  miR-512-5p suppresses tumor growth by targeting hTERT in telomerase positive head and neck squamous cell carcinoma in vitro and in vivo.

Authors:  Jun Li; Han Lei; Yong Xu; Ze-Zhang Tao
Journal:  PLoS One       Date:  2015-08-10       Impact factor: 3.240

View more
  4 in total

1.  MUC1 confers radioresistance in head and neck squamous cell carcinoma (HNSCC) cells.

Authors:  Tian-Qiao Huang; Ya-Nan Bi; Zheng Cui; Jin-Ping Guan; Yi-Chuan Huang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

2.  Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.

Authors:  Suo Liu; Zhibin Jiang; Peng Xiao; Xiaozhi Li; Yinji Chen; Hao Tang; Yanfei Chai; Yicai Liu; Zhao Zhu; Qianyi Xie; Wei He; Yuchao Ma; Longyu Jin; Wei Feng
Journal:  Cancer Sci       Date:  2021-11-15       Impact factor: 6.716

Review 3.  Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.

Authors:  Wei Li; Yineng Han; Chenmin Sun; Xue Li; Junhua Zheng; Jianping Che; Xudong Yao; Donald Kufe
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 4.  The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer.

Authors:  Rina Masadah; Syahrul Rauf; Muhammad Yogi Pratama; Claudio Tiribelli; Devis Pascut
Journal:  Cancers (Basel)       Date:  2021-03-09       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.